|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00389012 |
|
Date of registration:
|
16/10/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Strength Training Effectiveness Post-Stroke (STEPS)
|
|
Scientific title:
|
Strength Training Effectiveness Post-Stroke (STEPS) |
|
Date of first enrolment:
|
May 2004 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00389012 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
David A Brown, PhD, PT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Department of Physical Therapy and Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois |
|
|
Name:
|
Katherine J Sullivan, PhD, PT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Division of Biokinesiology and Physical Therapy, University of Southern California, Los Angeles, California |
|
|
Name:
|
Sara Mulroy, PhD, PT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Pathokinesiology Laboratory, Rancho Los Amigos National Rehabilitation Center, Downey, California |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age 18 years or older
- 4 months to 5 years after first-time onset of a ischemic or hemorrhagic cerebrovascular accident (CVA) confirmed by CT, MRI, or clinical criteria
- able to ambulate at least 14 meters with assistive and/or orthotic device and one person assist (minimum Functional Ambulation Classification Level II
- self-selected walking velocity of =1.0 meters/second
- approval of primary care physician to participate.
Exclusion Criteria:
- resting systolic blood pressure greater than 180mmHg and/or diastolic blood pressure greater than 110mmHg and/or resting heart rate greater than 100 beats/minute;
- lower limb orthopedic conditions such as prior joint replacement or range of motion limitations;
- spasticity management that included Botox injection (< 4 months earlier) or phenol block injection (< 12 months earlier) to affected lower extremity and intrathecal Baclofen or oral Baclofen (within past 30 days);
- Mini-Mental State Exam score < 24;
- currently receiving lower extremity strengthening exercises or gait training,
- past participation in any study examining the effects of long term (>4 weeks training) body weight support treadmill training; limb loaded pedaling, or lower extremity strengthening;
- plans to move out of the area in the next year,
- no transportation to the study site for all evaluations and intervention sessions.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cerebrovascular Accident
|
|
Intervention(s)
|
|
Procedure: exercise therapy
|
|
Procedure: walking rehabilitation
|
|
Primary Outcome(s)
|
|
walking distance (distance walked in 6-minutes)
|
|
walking speed (meters/second)
|
|
Secondary Outcome(s)
|
|
Berg Balance Score
|
|
Lower extremity Fugl-Meyer
|
|
Lower extremity torque
|
|
SF-36
|
|
Stroke Impact Scale
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|